DPPA4 anticorps (AA 11-264)
Aperçu rapide pour DPPA4 anticorps (AA 11-264) (ABIN7149824)
Antigène
Voir toutes DPPA4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 11-264
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Developmental pluripotency-associated protein 4 protein (11-264AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- DPPA4 (Developmental Pluripotency Associated 4 (DPPA4))
-
Autre désignation
- DPPA4
-
Sujet
-
Background: May be involved in the maintenance of active epigenetic status of target genes. May inhibit differentiation of embryonic cells into a primitive ectoderm lineage.
Aliases: 2410091M23Rik antibody, Developmental pluripotency associated 4 antibody, Developmental pluripotency associated protein 4 antibody, Developmental pluripotency-associated protein 4 antibody, Dppa 4 antibody, DPPA4 antibody, DPPA4_HUMAN antibody, FLJ10713 antibody
-
UniProt
- Q7L190
Antigène
-